Intuitive Surgical, Inc. $ISRG Shares Acquired by Simon Quick Advisors LLC

Simon Quick Advisors LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 84.3% during the second quarter, HoldingsChannel.com reports. The fund owned 4,546 shares of the medical equipment provider’s stock after acquiring an additional 2,080 shares during the quarter. Simon Quick Advisors LLC’s holdings in Intuitive Surgical were worth $2,470,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. Aaron Wealth Advisors LLC grew its holdings in Intuitive Surgical by 0.8% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after buying an additional 19 shares during the last quarter. FSM Wealth Advisors LLC grew its holdings in Intuitive Surgical by 3.8% during the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock valued at $270,000 after buying an additional 20 shares during the last quarter. CFO4Life Group LLC grew its holdings in Intuitive Surgical by 4.8% during the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock valued at $216,000 after buying an additional 20 shares during the last quarter. J. W. Coons Advisors LLC grew its holdings in Intuitive Surgical by 1.4% during the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock valued at $741,000 after buying an additional 20 shares during the last quarter. Finally, Exencial Wealth Advisors LLC grew its holdings in Intuitive Surgical by 3.1% during the 1st quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock valued at $327,000 after buying an additional 20 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 1.4%

Shares of Intuitive Surgical stock opened at $530.02 on Friday. The firm has a market cap of $190.00 billion, a PE ratio of 70.11, a P/E/G ratio of 4.94 and a beta of 1.61. The business’s fifty day moving average is $463.16 and its two-hundred day moving average is $498.23. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business’s quarterly revenue was up 22.9% on a year-over-year basis. During the same period last year, the company posted $1.84 EPS. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have commented on ISRG. Royal Bank Of Canada set a $625.00 target price on Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Rothschild & Co Redburn increased their target price on Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Evercore ISI increased their target price on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Truist Financial set a $620.00 price target on Intuitive Surgical and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Finally, Jefferies Financial Group increased their price target on Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

Insiders Place Their Bets

In related news, Director Craig H. Barratt sold 2,193 shares of the stock in a transaction on Friday, October 24th. The stock was sold at an average price of $548.01, for a total value of $1,201,785.93. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO David J. Rosa sold 24,500 shares of the stock in a transaction on Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the transaction, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. This trade represents a 9.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 96,011 shares of company stock worth $50,309,042. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.